Hokan Inc. appointed Nagami Seio (永見 世央), Tsukamoto Masato (裙本 理人) and Nagai Junpei (永井 淳平) as 3 outside directors. The company outlined a policy of advancing new business development and M&A by strengthening governance and drawing on expertise in capital markets and regulated industries.
Nagami Seio (永見 世央), Tsukamoto Masato (裙本 理人) and Nagai Junpei (永井 淳平) were appointed as outside directors. Nagami Seio (永見 世央) brings practical expertise in capital markets, including his experience as CEO of ラクスル; Tsukamoto Masato (裙本 理人) brings experience creating businesses in regenerative medicine and taking a company public; and Nagai Junpei (永井 淳平) brings practical experience in finance, corporate planning and investor relations at a listed company.
The objectives of the new structure include enhancing the effectiveness of corporate governance and bringing expertise in capital markets, regulated industries, startup management and M&A to the board of directors. The company also plans to build a structure that promotes new business development and strategic partnerships, rather than focusing solely on strengthening defensive governance.
Going forward, the company plans to become a platform company in the insurance industry by deepening its existing businesses and creating organic connections among them, while substantially expanding its business areas and the value it provides. It also indicated that it would accelerate new business development, strategic partnerships and M&A more rapidly than before.